Renowned Creative Director Margeaux Buttner at PROPELLER for 2024.

Portrait of Margeaux Buttner, an elite creative director in 2024, confidently standing in the futuristic office of PROPELLER, surrounded by innovative design projects and cutting-edge technology.

Elite 2024 Creative Director Margeaux Buttner of PROPELLER In an industry where innovation and creativity are paramount, Margeaux Buttner has emerged as a leading figure. As the newly appointed Creative Director at PROPELLER, a forward-thinking pharmaceutical marketing agency, Buttner is set to steer the creative direction into uncharted territories. Her appointment marks a significant milestone […]

FDA Panel Recommends Approval for Guardant Health’s Colon Cancer Detection Test.

A futuristic medical lab with scientists examining a glowing, innovative colon cancer screening device by Guardant Health, under the watchful eye of approving FDA advisers.

FDA Advisers Endorse Guardant Health’s Colon Cancer Screening Test In a pivotal step toward bolstering the arsenal against colorectal cancer, the advisory panel to the Food and Drug Administration (FDA) has rendered a positive recommendation for Guardant Health’s innovative colon cancer screening test. This endorsement, while not binding, paves the way for potential FDA approval […]

ASCO24: Preliminary Insights into Cancer Medication Research Outcomes

Digital illustration of a futuristic laboratory with scientists analyzing glowing test tubes containing experimental cancer drugs, with a visible display showing promising study results.

ASCO24: An Early Look at Cancer Drug Study Results The American Society of Clinical Oncology’s 2024 Conference (ASCO24) has once again illuminated the path of progress in cancer treatment, unveiling early results from a series of cutting-edge drug studies. These findings reflect a multi-faceted approach to cancer treatment, emphasizing targeted therapies, immunotherapies, and innovative combinations […]

Introducing the Enhanced Omnichannel: Elevating Your Unified Customer Experience

Detailed illustration of a futuristic retail store merging physical and digital realms, showcasing customers interacting with various technology touchpoints for a seamless shopping experience.

Welcome to Unified Customer Experience: The Next Level of Omnichannel In an era where the customer journey is more complex and fragmented than ever, healthcare companies are embracing a unified customer experience (UCX) as the next evolution of omnichannel marketing strategies. This approach promises to seamlessly integrate various communication channels, ensuring that customers receive a […]

Pfizer aims for additional savings with a new target of $1.5 billion in cost reductions.

An illustrative image showcasing a futuristic Pfizer laboratory with a digital dashboard displaying a graph chart where the $1.5 billion target is being achieved through innovative cost-cutting solutions, symbolizing efficiency and progress.

Pfizer Expands Cost Cuts with New $1.5B Target In a major strategy shift aimed at boosting profitability in a post-pandemic market, Pfizer Inc. has unveiled plans to implement additional cost-cutting measures aiming to save $1.5 billion by the end of the fiscal year. This move underscores the pharmaceutical giant’s commitment to streamline operations and focus […]

CDC urges states and cities to maintain high-level flu monitoring due to avian influenza risk.

A team of scientists and public health experts huddled over computers and lab equipment, analyzing data and samples, with a map displaying flu surveillance status across the United states in the background, amidst warnings of a bird flu threat.

CDC Urges Local Health Authorities to Maintain Vigilant Flu Surveillance Amid Bird Flu Concerns In response to the escalating threat posed by the avian influenza, the Centers for Disease Control and Prevention (CDC) has issued a directive to state and city health departments, advising them to sustain peak flu surveillance measures. This precautionary move underscores […]

AstraZeneca Plans to Boost Sales to $80 Billion Through Expanded Cancer Drug Portfolio

An artistic representation of AstraZeneca's metaphorical leap ahead in the pharmaceutical industry, showcasing a giant, futuristic pill bottle labeled with a cancer symbol, surrounded by smaller orbiting molecules, against a backdrop of an upward sales graph.

AstraZeneca’s $80B Sales Plan Leans on Cancer Drug Expansion In a bold move that underscores the pharmaceutical giant’s commitment to consolidating its position at the forefront of cancer treatment, AstraZeneca has unveiled an ambitious sales plan targeting $80 billion by 2030. This strategic pivot places a significant emphasis on the expansion of its cancer drug […]

STAT+: House Panel Invites PBM Executives to Testify.

An illustration of PBM executives sitting in a formal hearing before a House panel, with members of Congress questioning them, in a grand, detailed congressional hearing room.

House Panel Invites PBM Executives to Testify In a significant move that could have far-reaching implications for the pharmaceutical industry and healthcare policy, executives from leading Pharmacy Benefit Managers (PBMs) have been invited to testify before a House panel. The inquiry aims to shed light on the intricate mechanics of drug pricing and the substantial […]

Biotech firm Progentos, supported by Forbion, launches with a $65 million investment for an MS medication.

An innovative biotechnology laboratory with the logo of Progentos on the wall, scientists in lab coats analyzing a glowing vial labeled 'MS Treatment', surrounded by futuristic medical equipment and digital screens displaying molecular structures, with a background of financial graphs soaring upwards and a pile of $65M cash on a table.

Forbion-backed Biotech Progentos Debuts with $65M for MS Drug In a significant boost to the field of neurodegenerative diseases, Progentos, a newly formed biotechnology company, has secured an impressive $65 million in initial funding. This financial infusion, spearheaded by the leading European venture capital firm Forbion, positions Progentos at the forefront of developing innovative therapies […]